Knight Therapeutics Inc opened trading today at $5.30 and closed at $5.26. prices ranged from $5.26 to $5.38.

Shares slipped -1.13% from the previous day's close of $5.32.

Today across North America, the TSX Composite closed 0.08% at 22185.25, the S&P 500 closed -0.20% at 5243.77, the Dow Jones Industrial Average closed -0.60% at 39566.85 and the Nasdaq Composite closed 0.11% at 16396.83.

Knight Therapeutics Inc has listed on the Toronto Stock Exchange (TSX) under the ticker GUD.

Trading volume was 32,572 on 205 total trades. On average, Knight Therapeutics Inc has traded 54,887 shares over the last 5-days and 77,033 year-to-date.

The TSX overall saw 1,257 price advancers against 4,032 declines and 79 unchanged.

During the prior 52 weeks, GUD.TO has traded as high as $5.75 (January 22,2024) and low as $4.35 (October 23,2023). Moreover, in the last 12 months, Knight Therapeutics Inc's shares have boosted 19.55%, while this year, they have advanced 1.35%.

Following today's trading, Knight Therapeutics Inc has a market capitalization of $538.23 million on a float of 101,170 shares outstanding. Its annual EPS is $-0.16.

Knight Therapeutics Inc is a TSX Drug Specialty & Generic company headquartered in Montreal, CAN.

Based on 4.00 analysts, Knight Therapeutics Inc gets an average recommendation of "Moderate Buy" according to Zacks. Currently, there are 3 buy ratings and 1 hold ratings for the stock.

AI at The Globe and Mail
This report is produced using automated technology that summarizes market data into articles for our readers. Ongoing project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities..